|
Faith Pomeroy-Ward
Vice President, Corporate Development
 Faith Pomeroy-Ward has over a decade of corporate communications, marketing communications, and business development experience, with key roles in the pharmaceutical industry. Her expertise ranges from investor relations and internal communications to social media tactics and strategic partnerships, and she is an award-winning writer. She has worked on many high-profile brands including Mucinex®, Delsym®, Verizon®, Moxatag®, Cepacol®, BiDil®, Eylea® and Twinings®.
Pomeroy-Ward began her pharmaceutical career in 2004 with a role in the marketing department at Adams Respiratory Therapeutics, the maker of Mucinex®. In 2005, she was promoted to the investor relations/corporate communications function. When Adams was acquired by Reckitt Benckiser in 2008, Pomeroy-Ward joined Verizon Telecom in its public affairs department. She was then recruited to lead the investor relations and corporate communications function at MiddleBrook Pharmaceuticals. MiddleBrook was about to launch Moxatag®, the only FDA-approved once-a-day amoxicillin.
As Associate Vice President of Investor and Corporate Relations at MiddleBrook, Pomeroy-Ward managed all aspects of the company's corporate communications and investor relations programs. She also held key responsibilities within the business development and marketing functions. Pomeroy-Ward secured a promotional partnership for Moxatag® on a profit-share-only basis, increasing the volume of detailed healthcare prescribers fivefold. She also conceived and implemented a web-based contextual search and remarketing campaign which increased traffic to Moxatag.com by more than 500 percent. In 2010, Pomeroy-Ward began providing corporate communications, investor relations, and marketing communications consulting services. In 2011, she joined Alitair Pharmaceuticals as Vice President, Corporate Development.
Faith Pomeroy-Ward studied English Literature at Rutgers University and Communications at Thomas Edison State College. She holds a Certificate in Investor Relations from the University of California, Irvine. Pomeroy-Ward serves as a member of the Board of Directors for the award-winning Virtual Chapter of the National Investor Relations Institute (NIRI). In 2011, she was recognized with an Outstanding Performer Award for her contributions to the NIRI Virtual Chapter. In 2011, Pomeroy-Ward won an essay contest sponsored by the Dallas Fort Worth Chapter of NIRI. She is a Public Relations Society of America (PRSA) and Licensing Executives Society (LES) member.
|
